Skip to main content
Premium Trial:

Request an Annual Quote

Eurofins Opens New US Manufacturing, Services Facility

NEW YORK (GenomeWeb) – Eurofins Scientific announced today that it has opened a new manufacturing and genomic testing services facility in Louisville, Kentucky.

According to the company, the facility will function as its central genomics lab in North America, handling custom production of DNA and RNA oligonucleotides, synthetic gene synthesis, and genomic services including DNA sequencing, synthetic biology, and next-generation sequencing.

The company said it also plans to introduce new synthesis technology in the facility, and that the site will also house other activities such as food and microbiology testing.

Further, the new site is accessible to most major cities in the US, which should cut down on the turnaround time for delivery of genomic results and services, Eurofins added. 

"Our ambition is to make it the most modern and innovative facility of its kind in the world. This state-of-the-art laboratory reflects the [company's] commitment to quality, innovation, and to contributing to the advancement of scientific research and health sciences around the globe," CEO Gilles Martin said in a statement.

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.